Report Detail
Global Anthrax Vaccines Market Growth 2019-2024
- RnM2925080 |
- 11 February, 2019 |
- Global |
- 176 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.
Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.
South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.
South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.
Along with the development of China 's Agricultural technology, there is a lot Chinese local manufacturer can produce Anthrax Vaccines, with the increasing demand, more and more manufactures will go into Anthrax Vaccines industry.
Market competition is intense. Emergent BioSolutions is the major manufacturer of Anthrax Vaccines used for human, Merial, Merck, Zoetis, Bayer Sanidad Animal,Colorado Serum, etc. are is the major manufacturer of Anthrax Vaccines used for animal, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Anthrax Vaccines market will register a 7.5% CAGR in terms of revenue, the global market size will reach US$ 720 million by 2024, from US$ 500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anthrax Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.
This study considers the Anthrax Vaccines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Live Vaccines
Cell free PA Vaccines
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Human Use
Animal Use
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Anthrax Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anthrax Vaccines market by identifying its various subsegments.
Focuses on the key global Anthrax Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anthrax Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anthrax Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Anthrax Vaccines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Anthrax Vaccines Consumption 2014-2024
- 2.1.2 Anthrax Vaccines Consumption CAGR by Region
- 2.2 Anthrax Vaccines Segment by Type
- 2.2.1 Live Vaccines
- 2.2.2 Cell free PA Vaccines
- 2.3 Anthrax Vaccines Consumption by Type
- 2.3.1 Global Anthrax Vaccines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Anthrax Vaccines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Anthrax Vaccines Sale Price by Type (2014-2019)
- 2.4 Anthrax Vaccines Segment by Application
- 2.4.1 Human Use
- 2.4.2 Animal Use
- 2.5 Anthrax Vaccines Consumption by Application
- 2.5.1 Global Anthrax Vaccines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Anthrax Vaccines Value and Market Share by Application (2014-2019)
- 2.5.3 Global Anthrax Vaccines Sale Price by Application (2014-2019)
3 Global Anthrax Vaccines by Players
- 3.1 Global Anthrax Vaccines Sales Market Share by Players
- 3.1.1 Global Anthrax Vaccines Sales by Players (2017-2019)
- 3.1.2 Global Anthrax Vaccines Sales Market Share by Players (2017-2019)
- 3.2 Global Anthrax Vaccines Revenue Market Share by Players
- 3.2.1 Global Anthrax Vaccines Revenue by Players (2017-2019)
- 3.2.2 Global Anthrax Vaccines Revenue Market Share by Players (2017-2019)
- 3.3 Global Anthrax Vaccines Sale Price by Players
- 3.4 Global Anthrax Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Anthrax Vaccines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Anthrax Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Anthrax Vaccines by Regions
- 4.1 Anthrax Vaccines by Regions
- 4.1.1 Global Anthrax Vaccines Consumption by Regions
- 4.1.2 Global Anthrax Vaccines Value by Regions
- 4.2 Americas Anthrax Vaccines Consumption Growth
- 4.3 APAC Anthrax Vaccines Consumption Growth
- 4.4 Europe Anthrax Vaccines Consumption Growth
- 4.5 Middle East & Africa Anthrax Vaccines Consumption Growth
5 Americas
- 5.1 Americas Anthrax Vaccines Consumption by Countries
- 5.1.1 Americas Anthrax Vaccines Consumption by Countries (2014-2019)
- 5.1.2 Americas Anthrax Vaccines Value by Countries (2014-2019)
- 5.2 Americas Anthrax Vaccines Consumption by Type
- 5.3 Americas Anthrax Vaccines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Anthrax Vaccines Consumption by Countries
- 6.1.1 APAC Anthrax Vaccines Consumption by Countries (2014-2019)
- 6.1.2 APAC Anthrax Vaccines Value by Countries (2014-2019)
- 6.2 APAC Anthrax Vaccines Consumption by Type
- 6.3 APAC Anthrax Vaccines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Anthrax Vaccines by Countries
- 7.1.1 Europe Anthrax Vaccines Consumption by Countries (2014-2019)
- 7.1.2 Europe Anthrax Vaccines Value by Countries (2014-2019)
- 7.2 Europe Anthrax Vaccines Consumption by Type
- 7.3 Europe Anthrax Vaccines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Anthrax Vaccines by Countries
- 8.1.1 Middle East & Africa Anthrax Vaccines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Anthrax Vaccines Value by Countries (2014-2019)
- 8.2 Middle East & Africa Anthrax Vaccines Consumption by Type
- 8.3 Middle East & Africa Anthrax Vaccines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Anthrax Vaccines Distributors
- 10.3 Anthrax Vaccines Customer
11 Global Anthrax Vaccines Market Forecast
- 11.1 Global Anthrax Vaccines Consumption Forecast (2019-2024)
- 11.2 Global Anthrax Vaccines Forecast by Regions
- 11.2.1 Global Anthrax Vaccines Forecast by Regions (2019-2024)
- 11.2.2 Global Anthrax Vaccines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Anthrax Vaccines Forecast by Type
- 11.8 Global Anthrax Vaccines Forecast by Application
12 Key Players Analysis
- 12.1 Emergent BioSolutions
- 12.1.1 Company Details
- 12.1.2 Anthrax Vaccines Product Offered
- 12.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Emergent BioSolutions News
- 12.2 Merial
- 12.2.1 Company Details
- 12.2.2 Anthrax Vaccines Product Offered
- 12.2.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Merial News
- 12.3 Merck
- 12.3.1 Company Details
- 12.3.2 Anthrax Vaccines Product Offered
- 12.3.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Merck News
- 12.4 Zoetis
- 12.4.1 Company Details
- 12.4.2 Anthrax Vaccines Product Offered
- 12.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Zoetis News
- 12.5 Bayer Sanidad Animal
- 12.5.1 Company Details
- 12.5.2 Anthrax Vaccines Product Offered
- 12.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Bayer Sanidad Animal News
- 12.6 Colorado Serum
- 12.6.1 Company Details
- 12.6.2 Anthrax Vaccines Product Offered
- 12.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Colorado Serum News
- 12.7 PharmAthene
- 12.7.1 Company Details
- 12.7.2 Anthrax Vaccines Product Offered
- 12.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 PharmAthene News
- 12.8 Tiankang
- 12.8.1 Company Details
- 12.8.2 Anthrax Vaccines Product Offered
- 12.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Tiankang News
- 12.9 Biogénesis-Bago
- 12.9.1 Company Details
- 12.9.2 Anthrax Vaccines Product Offered
- 12.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Biogénesis-Bago News
- 12.10 CAVAC
- 12.10.1 Company Details
- 12.10.2 Anthrax Vaccines Product Offered
- 12.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 CAVAC News
- 12.11 Rosenbusch
- 12.12 Agrovet
- 12.13 Vecol
- 12.14 CVCRI
- 12.15 IVPM
- 12.16 Prondil
- 12.17 CDV
- 12.18 Indian Immunologicals
- 12.19 Botswana Vaccine Institute
- 12.20 Ceva Santé Animale
- 12.21 Intervac
- 12.22 JOVAC
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Anthrax Vaccines . Industry analysis & Market Report on Anthrax Vaccines is a syndicated market report, published as Global Anthrax Vaccines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Anthrax Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
